| Dr Ann Margaretha Lowe, MD | |
|
420 Cambridge Ave, Unit 3, Palo Alto, CA 94306-1507 | |
| (650) 323-6614 | |
| Not Available |
| Full Name | Dr Ann Margaretha Lowe |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Medical Oncology |
| Location | 420 Cambridge Ave, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013278811 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RX0202X | Internal Medicine - Medical Oncology | G50075 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ann Margaretha Lowe, MD Po Box 60699, Palo Alto, CA 94306-0699 Ph: (650) 323-6614 | Dr Ann Margaretha Lowe, MD 420 Cambridge Ave, Unit 3, Palo Alto, CA 94306-1507 Ph: (650) 323-6614 |
News Archive
A team of scientists, led by researchers at the University of California, San Diego School of Medicine, have uncovered a novel mechanism regulating gene expression and transcription linked to Spinocerebellar ataxia 7, an inherited neurological disorder.
An international research team led by the Institute of Bioengineering and Nanotechnology of the Agency for Science, Technology and Research and IBM Research developed a synthetic molecule that can kill five deadly types of multidrug-resistant bacteria with limited, if any, side effects.
Rosecrance, one of the country's leading teen substance abuse treatment centers, has launched a traveling art exhibit to help parents understand teenagers' points of view about pressures they encounter and how they are faced with the potential to use, and abuse, substances.
This is pointed out by the German Federal Institute for Risk Assessment (BfR) following the frequent occurrences of severe lung disorders amongst "vapers" in the USA. "According to current understanding, e-cigarette consumers in Germany do not face any increased risks, provided they continue to use products that comply with European and German regulations," says BfR President Professor Dr. Dr. Andreas Hensel."
Mercator Therapeutics, the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs, today announced the signing of a license agreement with The University of Texas MD Anderson Cancer Center and the closing of a $2.0 million seed round.
› Verified 6 days ago
Daniel Joseph Razzano, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Mahnoosh Kuhbanani Seifoddini, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Va Palo Alto Health Care System (111stc), Palo Alto, CA 94304 Phone: 209-946-3400 | |
Dr. Yusra Nazar Hussain, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 770 Welch Rd, Suite # 250, Palo Alto, CA 94304 Phone: 650-328-1676 Fax: 650-445-0911 | |
Dr. David Yao, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Medical Services (111a), Palo Alto, CA 94304 Phone: 650-493-5000 | |
Dr. Franklin Perry, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2175 Park Blvd, Palo Alto, CA 94306 Phone: 650-330-3688 Fax: 650-330-3686 | |
Dr. Ryan Arthur Mcconnell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2972 |